102940 — KOLON LIFE SCIENCE Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Market Cap
KR₩838bn
Enterprise Value
KR₩931bn
Revenue
KR₩209bn

Annual income statement for KOLON LIFE SCIENCE, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	165,485	161,584	124,639	161,387	208,982
Cost of Revenue
Gross Profit	37,202	37,139	12,411	16,868	55,891
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	165,939	161,823	151,867	219,550	192,932
Operating Profit	-454	-239	-27,228	-58,164	16,049
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-4,011	4,124	-33,598	-93,086	25,756
Provision for Income Taxes
Net Income After Taxes	-1,375	4,016	-33,599	-93,086	24,960
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-1,375	2,133	-30,726	-93,086	24,960
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-1,375	2,133	-30,726	-93,086	26,135
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	122	491	-2,765	-4,688	1,929
Dividends per Share